NCT04423939View on ClinicalTrials.gov

ACT to Reduce Morbidity and Mortality in Hematopoietic Stem Cell Transplant (HCT) Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

October 14, 2020

Primary Completion Date

May 19, 2022

Study Completion Date

February 17, 2025

Conditions
Hematopoietic Steam Cell Transplantation (HCT)
Interventions
BEHAVIORAL

Acceptance and Commitment Therapy (ACT)

The ACT sessions will be tailored to the clinical challenges of HCT. Sessions are with a mental health professional and are 45-60 minutes in duration and include both the participant and caregiver.

Trial Locations (1)

27608

Lauren Hill, Raleigh

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER